3SQ-28519-60837
2 vaccinations
1 coded response
23 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 324 / FL
- Registered
- 2021-07-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-12
Registered in v-safe
-
2021-07-12
Dose 1 — Pfizer-BioNTech
- 2021-07-12
- 2021-07-13
- 2021-07-14
- 2021-07-15
- 2021-07-16
- 2021-07-17
- 2021-07-18
- 2021-07-21
- 2021-07-26
-
2021-08-02
Dose 2 — Pfizer-BioNTech
- 2021-08-02
- 2021-08-03
- 2021-08-04
- 2021-08-05
-
2021-08-07
Survey response — days 1–6 daily, dose 2MedDRA: Migraine — Feeling: Fair · Headache · Be unable to do your normal daily activitiesFree text: MigraineMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-08-08
- 2021-08-16
- 2021-08-23
- 2021-08-30
- 2021-09-06
- 2021-09-13
- 2021-11-01
- 2022-01-31
- 2022-08-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-12 | Pfizer-BioNTech | No |
| 2 | 2021-08-02 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Migraine
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Migraine | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release